Studies on Glycogen and cancer

Estimation of Glycogen levels in human colorectal cancer tissue: relationship with cell cycle and tumor outgrowth.
1999 Journal of gastroenterology

Estimation of Glycogen levels in human colorectal cancer tissue: relationship with cell cycle and tumor outgrowth.
1999 Journal of gastroenterology

Estimation of Glycogen levels in human colorectal cancer tissue: relationship with cell cycle and tumor outgrowth.
1999 Journal of gastroenterology

Estimation of Glycogen levels in human colorectal cancer tissue: relationship with cell cycle and tumor outgrowth.
1999 Journal of gastroenterology

Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.
2010 Clinical cancer research : an official journal of the American Association for cancer Research

Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells.
2006 Cell research

Activation of p53-dependent apoptosis by acute ablation of Glycogen synthase kinase-3beta in colorectal cancer cells.
2005 Clinical cancer research : an official journal of the American Association for cancer Research

Aberrant nuclear accumulation of Glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
2006 Clinical cancer research : an official journal of the American Association for cancer Research

Suppression of Glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo.
2010 The Prostate

Suppression of Glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo.
2011 The Prostate

Maintenance of constitutive IkappaB kinase activity by Glycogen synthase kinase-3alpha/beta in pancreatic cancer.
2008 Cancer research

Glycogen content in the gastric mucosa of partially resected stomach; a possible relationship with the development of cancer.
1998 Cancer letters

Glycogen synthase kinase 3 beta: can it be a target for oral cancer.
2010 Molecular cancer

Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy.
2009 Cancer letters

Detection of active fraction of Glycogen synthase kinase 3beta in cancer cells by nonradioisotopic in vitro kinase assay.
2006 Oncology

Glycogen content in the gastric mucosa of partially resected stomach; a possible relationship with the development of cancer.
1998 Cancer letters

An emerging strategy for cancer treatment targeting aberrant Glycogen synthase kinase 3 beta.
2009 Anti-cancer agents in medicinal chemistry

Glycogen content in the gastric mucosa of partially resected stomach; a possible relationship with the development of cancer.
1998 Cancer letters

Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer.
2003 Molecular cancer therapeutics

Myeloid cell leukemia-1 inversely correlates with Glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer.
2007 Cancer research

Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated Glycogen synthase kinase-3beta with p53.
2008 Oncogene

Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of Glycogen synthase kinase-3beta activity.
2009 Cancer research

From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as Glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.
2009 Journal of medicinal chemistry

Glycogen synthase kinase-3 beta; a new target in pancreatic cancer?
2007 Current cancer drug targets

Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.
2005 Cancer research

Expression of cyclooxygenase-2 is regulated by Glycogen synthase kinase-3beta in gastric cancer cells.
2006 The Journal of biological chemistry

Reciprocal targeting of Hath1 and beta-catenin by Wnt Glycogen synthase kinase 3beta in human colon cancer.
2007 Gastroenterology

Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
2004 Endocrinology

Glycogen synthase kinase 3beta induces apoptosis in cancer cells through increase of survivin nuclear localization.
2008 Cancer letters

O-GlcNAc protein modification in cancer cells increases in response to glucose deprivation through Glycogen degradation.
2009 The Journal of biological chemistry

Glycogen synthase kinase-3 does not correlate with the expression and activity of -catenin in gastric cancer.
2010 APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of Glycogen synthase kinase-3beta.
2009 Molecular cancer therapeutics

Inhibition of Glycogen synthase kinase-3 in androgen-responsive prostate cancer cell lines: are GSK inhibitors therapeutically useful?
2008 Neoplasia (New York, N.Y.)

Association of cellular localization of Glycogen synthase kinase 3beta in the digestive tract with cancer development.
2009 Oncology reports

Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to Glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B.
2005 Cancer research

P27Kip1, regulated by Glycogen synthase kinase-3beta, results in HMBA-induced differentiation of human gastric cancer cells.
2011 BMC cancer

Role of Glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways.
2002 Advances in cancer research

Mechanism of depletion of liver Glycogen in cancer cachexia.
1997 Biochemical and biophysical research communications

Inactivation of Glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
2007 Molecular cancer therapeutics

Insulin resistance and tissue Glycogen content in the tumor-bearing state.
1999 Hepato-gastroenterology

Mechanism of depletion of liver Glycogen in cancer cachexia.
1997 Biochemical and biophysical research communications

Role of Glycogen synthase kinase 3 beta (GSK3beta) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells.
2006 Molecular cancer

Pharmacologic modulation of Glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells.
2005 Cancer research

Mechanism of depletion of liver Glycogen in cancer cachexia.
1997 Biochemical and biophysical research communications

Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation.
2002 Medicinal research reviews

Mechanism of depletion of liver Glycogen in cancer cachexia.
1997 Biochemical and biophysical research communications

Apical membrane localization of Glycogen synthase kinase 3beta protein in normal colon epithelium and aberrant distribution in colorectal cancer.
2009 Cancer letters

Prodigiosin induces the proapoptotic gene NAG-1 via Glycogen synthase kinase-3beta activity in human breast cancer cells.
2007 Molecular cancer therapeutics

Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy.
2009 BMC cancer

Inhibition of Glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines.
2010 Journal of cellular biochemistry

Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein.
2010 The Journal of pharmacology and experimental therapeutics

Clinical and biological significance of GSK-3 inactivation in breast cancer-an immunohistochemical study.
2010 Human pathology

Cytoplasmic accumulation of Glycogen synthase kinase-3beta is associated with aggressive clinicopathological features in human prostate cancer.
2009 Anticancer research

p27 Kip1 nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by Glycogen synthase kinase-3 in human colon cancer cells.
2008 Cell death and differentiation

Glycogen synthase kinase-3 and cancer: good cop, bad cop?
2008 Cancer cell

Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type Glycogen phosphorylase.
1999 Journal of experimental & clinical cancer research : CR

Activity of Glycogen synthase kinase-3beta is down-regulated during transient differentiation of human colon cancer HT-29 cells.
1999 Oncology reports

Phosphorylation of Glycogen synthase kinase-3 beta at serine 9 confers cisplatin resistance in ovarian cancer cells.
2007 International journal of oncology

Anticancer efficacy of deguelin in human prostate cancer cells targeting Glycogen synthase kinase-3 β/β-catenin pathway.
2011 International journal of cancer. Journal international du cancer

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma.
2009 British journal of cancer

Unlocking the ultrastructure of colorectal cancer cells in vitro using selective staining.
2010 World journal of gastroenterology : WJG

Akt/protein kinase b and Glycogen synthase kinase-3beta signaling pathway regulates cell migration through the NFAT1 transcription factor.
2009 Molecular cancer research : MCR

Glycogen synthase kinase 3beta regulates cell death induced by synthetic triterpenoids.
2008 Cancer research